Author Correction: Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.
Nancy S YounisAmal M H GhanimSameh SaberPublished in: Scientific reports (2022)